Many people take medications known as statins to lower their cholesterol levels and reduce the risk of heart disease. One commonly used statin is rosuvastatin.
However, a recent study has raised concerns about rosuvastatin’s potential impact on the kidneys.
This study, published in the Journal of the American Society of Nephrology, suggests that rosuvastatin use, particularly at higher doses, might be associated with kidney problems.
Understanding Cholesterol and Statins
Cholesterol is a fatty substance in our blood. While our bodies need some cholesterol to function properly, having too much of it can lead to health issues, especially heart disease.
Statin medications like rosuvastatin are prescribed to lower high cholesterol levels and reduce the risk of heart-related problems.
The Research Study
To investigate the potential kidney risks linked to rosuvastatin, researchers led by Dr. Jung-Im Shin from the Johns Hopkins Bloomberg School of Public Health conducted a study.
They examined the medical records of people who had recently started taking either rosuvastatin or another similar medication called atorvastatin. The study covered data from 2011 to 2019.
Findings
Kidney Concerns: During the study period (which lasted for about 3.1 years on average), researchers noticed some kidney-related issues.
Hematuria, which means blood in the urine, was found in 2.9% of patients, and 1.0% of patients had proteinuria, indicating the presence of excess protein in the urine.
When they compared rosuvastatin to atorvastatin, rosuvastatin users had an 8% higher risk of hematuria, a 17% higher risk of proteinuria, and a 15% higher risk of kidney failure requiring replacement therapy like dialysis or transplantation.
Dose Matters: The study also uncovered an important point: the risk of hematuria and proteinuria seemed to increase with higher doses of rosuvastatin.
In simpler terms, taking more of this medication appeared to be linked to a higher risk of these kidney-related problems.
Concerns for Advanced Kidney Disease: Alarmingly, when it came to patients with advanced kidney disease, nearly half of them were given higher doses of rosuvastatin than what’s recommended for individuals with poor kidney function by the US Food and Drug Administration.
Conclusion
The study’s findings indicate that using rosuvastatin may be associated with certain kidney risks, especially when taken in higher doses.
It’s important to note that while rosuvastatin provides similar heart-related benefits as atorvastatin, it might carry a greater risk of kidney issues, such as hematuria and proteinuria. This is a concerning discovery, especially for individuals who already have kidney problems.
Dr. Jung-Im Shin emphasizes that although the risk is relatively small, it should be taken into consideration, especially for patients with kidney concerns.
This study underscores the need for healthcare providers and patients to have open and informed discussions about medication options.
It’s crucial to weigh the potential benefits and risks, especially when it comes to medications that affect both heart health and kidney function.
Individualized treatment plans and careful monitoring may be necessary to ensure the best possible outcomes for patients’ overall health.
If you care about health, please read studies about berry that can prevent cancer, diabetes, and obesity, and 12 foods that lower blood pressure.
For more information about health, please see recent studies about diet to fight diabetic eye damage, and results showing these antioxidants could help reduce dementia risk.
The research findings can be found in the Journal of the American Society of Nephrology.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
